STOCK TITAN

Takeda (NYSE: TAK) grants 22,570 RSUs to chief HR executive

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Greenway Nicola Deidre Petal reported acquisition or exercise transactions in this Form 4 filing.

Takeda Pharmaceutical reported that Chief Human Resources Officer Nicola Deidre Petal Greenway received an equity award of 22,570 American Depositary Shares in the form of restricted stock units (RSUs). The units were granted at no cash cost to her as compensation.

Each RSU represents a contingent right to one American Depositary Share and will vest in three equal annual installments beginning on July 1, 2027. After this award, Greenway directly holds 94,406 American Depositary Shares, highlighting a meaningful ongoing equity stake that ties her compensation to Takeda’s long-term performance.

Positive

  • None.

Negative

  • None.
Insider Greenway Nicola Deidre Petal
Role Chief Human Resources Officer
Type Security Shares Price Value
Grant/Award American Depositary Shares 22,570 $0.00 --
Holdings After Transaction: American Depositary Shares — 94,406 shares (Direct)
Footnotes (1)
  1. [object Object]
RSUs granted 22,570 American Depositary Shares Equity award to Chief Human Resources Officer
Holdings after transaction 94,406 American Depositary Shares Direct ownership following RSU grant
Vesting schedule Three equal annual installments Beginning on July 1, 2027
restricted stock units (RSUs) financial
"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right..."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
American Depositary Shares financial
"Each RSU represents a contingent right to receive one American Depositary Share."
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
vest in three equal annual installments financial
"The RSUs vest in three equal annual installments beginning on July 1, 2027."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Takeda (TAK) report for Nicola Greenway?

Takeda reported that Chief Human Resources Officer Nicola Greenway received an award of 22,570 restricted stock units. Each RSU equals one American Depositary Share, granted at no cash cost as part of her equity-based compensation.

How many Takeda (TAK) shares does Nicola Greenway hold after this Form 4?

After the reported grant, Nicola Greenway holds 94,406 American Depositary Shares directly. This figure includes the newly awarded 22,570 RSU-linked shares, reflecting her total direct equity exposure as shown in the Form 4 filing.

What are the vesting terms of Nicola Greenway’s RSUs at Takeda (TAK)?

The 22,570 restricted stock units vest in three equal annual installments starting July 1, 2027. This time-based schedule spreads the compensation over several years, encouraging longer-term alignment with Takeda’s performance and executive retention.

What does the RSU award in Takeda (TAK) stock mean for Nicola Greenway?

The RSU award gives Nicola Greenway a contingent right to 22,570 Takeda American Depositary Shares over time. She receives the shares only as they vest, linking a portion of her pay to Takeda’s share performance and continued service.

Was Nicola Greenway’s Takeda (TAK) RSU grant an open-market purchase or compensation?

The transaction was a compensation-related grant, not an open-market purchase. The Form 4 describes it as a grant or award acquisition with a per-share transaction price of zero, indicating it forms part of her executive compensation package.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Greenway Nicola Deidre Petal

(Last)(First)(Middle)
500 KENDALL STREET

(Street)
CAMBRIDGE MASSACHUSETTS 02142

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Human Resources Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
American Depositary Shares07/01/2026A(1)22,570A$094,406D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.
Remarks:
/s/ Kate Huleatt, by power of attorney, for Nicola D. Greenway07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)